MD, MS: Peking University Health Science Center, Beijing, China.
PhD: Rutgers University, New Brunswick, NJ.
MBA: Carl H. Lindner College of Business, University of Cincinnati, Cincinnati, OH
Fellowship: Clinical Molecular Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.
Certification: American Board of Medical Genetics in Clinical Molecular Genetics, 2011; American Board of Medical Genetics in Labratory of Genetics and Genomics, 2021.
Clinical molecular genetics; whole exome sequencing; whole genome sequencing; RNAseq; molecular genetic diagnosis of hereditary cardiovascular diseases; genetic blood disorders; and other genetic conditions
The Role of Pancreatitis Risk Genes in Endocrine Insufficiency Development After Acute Pancreatitis in Children. Clinical Gastroenterology and Hepatology. 2024; 22(10):2033-2043.e2.
Genetic Testing in Patients with Autoimmune Lymphoproliferative Syndrome: Experience of 802 Patients at Cincinnati Children's Hospital Medical Center. Journal of Clinical Immunology. 2024; 44(7):166.
Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen Low Penetrance/Risk Allele Working Group. Genetics in Medicine. 2024; 26(3):101036.
RNA sequencing reveals a complete picture of a homozygous missense variant in a patient with VPS13D movement disorder: a case report and review of the literature. Molecular Genetics and Genomics. 2023; 298(5):1185-1199.
Hemolytic anemia and macrothrombocytopenia: A lipid problem? American Journal of Hematology. 2023; 98(8):1335-1340.
Genetic Testing in Patients with Neurodevelopmental Disorders: Experience of 511 Patients at Cincinnati Children's Hospital Medical Center. Journal of Autism and Developmental Disorders. 2022; 52(11):4828-4842.
Desmoplakin and periplakin genetically and functionally contribute to eosinophilic esophagitis. Nature Communications. 2021; 12(1):6795.
Epilepsy phenotypes associated with MAP1B-related brain malformations. Epileptic Disorders. 2021; 23(2):392-396.
Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy. American Journal of Medical Genetics, Part A. 2019; 179(4):608-614.